These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6227251)

  • 1. Insulin resistance in polycystic ovary syndrome.
    Shoupe D; Kumar DD; Lobo RA
    Am J Obstet Gynecol; 1983 Nov; 147(5):588-92. PubMed ID: 6227251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome.
    Dunaif A; Mandeli J; Fluhr H; Dobrjansky A
    J Clin Endocrinol Metab; 1988 Jan; 66(1):131-9. PubMed ID: 2961783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia.
    Dunaif A; Graf M; Mandeli J; Laumas V; Dobrjansky A
    J Clin Endocrinol Metab; 1987 Sep; 65(3):499-507. PubMed ID: 3305551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance in nonobese patients with polycystic ovarian disease.
    Chang RJ; Nakamura RM; Judd HL; Kaplan SA
    J Clin Endocrinol Metab; 1983 Aug; 57(2):356-9. PubMed ID: 6223044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated bioactive luteinizing hormone in women with the polycystic ovary syndrome.
    Lobo RA; Kletzky OA; Campeau JD; diZerega GS
    Fertil Steril; 1983 May; 39(5):674-8. PubMed ID: 6220924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of androgens on insulin resistance.
    Shoupe D; Lobo RA
    Fertil Steril; 1984 Mar; 41(3):385-8. PubMed ID: 6230259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome.
    Lobo RA; Goebelsmann U; Horton R
    J Clin Endocrinol Metab; 1983 Aug; 57(2):393-7. PubMed ID: 6223045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine abnormalities in ovulatory women with polycystic ovaries on ultrasound.
    Carmina E; Wong L; Chang L; Paulson RJ; Sauer MV; Stanczyk FZ; Lobo RA
    Hum Reprod; 1997 May; 12(5):905-9. PubMed ID: 9194637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose intolerance in Japanese patients with polycystic ovary syndrome.
    Kurioka H; Takahashi K; Miyazaki K
    Arch Gynecol Obstet; 2007 Mar; 275(3):169-73. PubMed ID: 16972071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The control of bioactive luteinizing hormone secretion in women with polycystic ovary syndrome.
    Lobo RA; Shoupe D; Chang SP; Campeau J
    Am J Obstet Gynecol; 1984 Feb; 148(4):423-8. PubMed ID: 6364811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of rosiglitazone in obese women with polycystic ovary syndrome and severe insulin resistance.
    Sepilian V; Nagamani M
    J Clin Endocrinol Metab; 2005 Jan; 90(1):60-5. PubMed ID: 15483106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
    Rittmaster RS; Thompson DL
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance in nonobese patients with polycystic ovary syndrome.
    Toprak S; Yönem A; Cakir B; Güler S; Azal O; Ozata M; Corakçi A
    Horm Res; 2001; 55(2):65-70. PubMed ID: 11509861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polycystic ovaries in adolescents and the relationship with menstrual cycle patterns, luteinizing hormone, androgens, and insulin.
    van Hooff MH; Voorhorst FJ; Kaptein MB; Hirasing RA; Koppenaal C; Schoemaker J
    Fertil Steril; 2000 Jul; 74(1):49-58. PubMed ID: 10899496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of hyperinsulinemia and insulin resistance by opiate receptor blockade in the polycystic ovary syndrome with acanthosis nigricans.
    Givens JR; Kurtz BR; Kitabchi AE; Bittle JB; Karas JG; Mitchell JA; Howes JF
    J Clin Endocrinol Metab; 1987 Feb; 64(2):377-82. PubMed ID: 3539980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of obesity and hyperinsulinemia in the insulin resistance of obese subjects with the clinical triad of polycystic ovaries, hirsutism and acanthosis nigricans.
    Wajchenberg BL; Giannella-Neto D; Lerario AC; Marcondes JA; Ohnuma LY
    Horm Res; 1988; 29(1):7-13. PubMed ID: 3397043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular disease risk characteristics of the main polycystic ovary syndrome phenotypes.
    Dilbaz B; Ozkaya E; Cinar M; Cakir E; Dilbaz S
    Endocrine; 2011 Jun; 39(3):272-7. PubMed ID: 21547513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of insulin resistance in the idiopathic hirsutism.
    Sarac F; Saygili F; Ozgen G; Tuzun M; Yilmaz C; Kabalak T
    Gynecol Obstet Invest; 2007; 63(3):126-31. PubMed ID: 17057397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serum dehydroepiandrosterone sulfate levels in patients with insulin resistance, hirsutism, and acanthosis nigricans.
    Alper MM; Garner PR
    Fertil Steril; 1987 Feb; 47(2):255-8. PubMed ID: 2950000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome.
    Adams JM; Taylor AE; Crowley WF; Hall JE
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4343-50. PubMed ID: 15356031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.